Cristin L. Rothfuss - 07 Mar 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Signature
/s/ Cristin Rothfuss
Issuer symbol
SRPT
Transactions as of
07 Mar 2025
Net transactions value
-$153,269
Form type
4
Filing time
10 Mar 2025, 20:00:06 UTC
Previous filing
06 Mar 2025
Next filing
11 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability $117,285 -1,131 -8.5% $103.70 12,194 07 Mar 2025 Direct F1
transaction SRPT Common Stock Tax liability $35,984 -347 -2.8% $103.70 11,847 07 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023.
F2 Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.